Our previous work showed that breast cancer stem cells express CD44+CD24− (Al-Hajj et al., 2003) or ALDH+ (Ginestier et al., 2007), and that these two markers isolate distinct populations of mesenchymal-like and epithelial-like cells, respectively (Liu et al., 2013). This evidence concerns the gene CD44 and breast cancer.